Phage Pharma appoints David Jackson
Published on: 27/07/10
US clinical-stage development and manufacturing company Phage Pharmaceuticals has appointed David Jackson VP of operations planning.
He will be responsible for oversight of the company’s cGMP-certified therapeutic protein manufacturing facility in San Diego and reports to chief executive Robert Beckman.
Prior to joining Phage, David was VP of process development and manufacturing at VaxInnate Corporation, and has previously served as VP of US operations and later VP of global biologics manufacturing at Lonza Biologics.
His previous roles also include VP of manufacturing at BioReliance and VP of manufacturing and pharmaceutical support at EntreMed.
Mission Statement
InPharm.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma jobs, pharma events, and pharma service company listings.
Site content is produced by our editorial team for InPharm.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches
